Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Smad transcription factors are intracellular proteins that mediate signaling by the transforming growth factor-beta (TGF-β) superfamily, including TGF-βs, activins, and bone morphogenetic proteins (BMPs). They are crucial for regulating gene expression programs involved in diverse cellular processes such as proliferation, differentiation, apoptosis, and development. Smads are classified into R-Smads (receptor-regulated), Co-Smad (common-mediator), and I-Smads (inhibitory), each playing a distinct role in the signaling pathway. Upon activation by cell surface receptors, R-Smads form complexes with Co-Smad4 and translocate to the nucleus to regulate target gene expression, often in cooperation with other transcription factors. Smad activity is tightly regulated by phosphorylation, ubiquitination, and interactions with other proteins.
Modulation of gene expression via DNA binding and interaction with co-factors after activation by TGF-β superfamily receptors.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Smad Transcription Factors (Smad).